Ultragenyx Pharmaceutical Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ABOS
|
Acumen Pharmaceuticals, Inc. | $2.53 | $157.41 M | -2.5 | 51 | $0 |
 ALNY
|
Alnylam Pharmaceuticals, Inc. | $270.29 | $19.33 B | -57.65 | 2100 | $1.83 B |
 AMLX
|
Amylyx Pharmaceuticals, Inc. | $2.67 | $120.37 M | -1.65 | 384 | $380.79 M |
 APLS
|
Apellis Pharmaceuticals, Inc. | $36.33 | $4.90 B | -11.77 | 702 | $396.59 M |
 ARVN
|
Arvinas, Inc. | $25.16 | $1.83 B | -4.41 | 445 | $78.50 M |
 CRNX
|
Crinetics Pharmaceuticals, Inc. | $53.94 | $3.53 B | -11.86 | 290 | $4.01 M |
 DAWN
|
Day One Biopharmaceuticals, Inc. | $13.62 | $1.12 B | -5.11 | 169 | $0 |
 INCY
|
Incyte Corporation | $66.45 | $13.30 B | 17.93 | 2524 | $3.70 B |
 INZY
|
Inozyme Pharma, Inc. | $5.98 | $286.39 M | -3.43 | 59 | $0 |
 KURA
|
Kura Oncology, Inc. | $20.87 | $1.66 B | -10.03 | 142 | $0 |
 MRTX
|
Mirati Therapeutics, Inc. | $58.70 | $4.12 B | -4.82 | 587 | $12.44 M |
 PDSB
|
PDS Biotechnology Corporation | $3.06 | $106.92 M | -2.13 | 25 | $0 |
 RVMD
|
Revolution Medicines, Inc. | $44.53 | $6.66 B | -10.51 | 443 | $11.58 M |
 TERN
|
Terns Pharmaceuticals, Inc. | $9.40 | $462.44 M | -5.67 | 66 | $0 |
 UTHR
|
United Therapeutics Corporation | $344.87 | $12.20 B | 13.02 | 1168 | $2.33 B |
 XFOR
|
X4 Pharmaceuticals, Inc. | $0.65 | $169.62 M | -1.51 | 127 | $0 |